STELLAR-311

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

ZanzalintinibOngoingRecruitingPhase 2Open NCT06943755 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

STELLAR-311 · Trial Tracker · ComplyRx